Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Other Working Capital Changes (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Other Working Capital Changes for 8 consecutive years, with -$2.7 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes rose 95.42% to -$2.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.3 million through Dec 2025, up 94.34% year-over-year, with the annual reading at -$3.3 million for FY2025, 94.34% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$2.7 million at Precision Biosciences, down from -$541000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $92.9 million in Q1 2021, with the low at -$86.8 million in Q2 2021.
  • Average Other Working Capital Changes over 5 years is -$3.4 million, with a median of -$1.5 million recorded in 2023.
  • Peak annual rise in Other Working Capital Changes hit 3059.99% in 2021, while the deepest fall reached 6080.0% in 2021.
  • Over 5 years, Other Working Capital Changes stood at -$8.0 million in 2021, then crashed by 352.69% to -$36.2 million in 2022, then surged by 201.17% to $36.7 million in 2023, then tumbled by 263.61% to -$60.0 million in 2024, then surged by 95.42% to -$2.7 million in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$2.7 million, -$541000.0, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.